151 related articles for article (PubMed ID: 37121510)
1. Subcutaneous plasma-derived C1 inhibitor for long-term prophylaxis during pregnancy and breast-feeding in a patient with factor XII hereditary angioedema.
Herraez L; Álvarez Sala P; Mielgo R
J Allergy Clin Immunol Pract; 2023 Aug; 11(8):2587-2588. PubMed ID: 37121510
[No Abstract] [Full Text] [Related]
2. Successful perinatal management of hereditary angioedema with normal C1 esterase inhibitor and factor XII mutation using C1 esterase inhibitor therapy.
Gibbons KR; Abraham T; Sandhu M; Peppers BP; Girzhel JF; Hostoffer RW
Ann Allergy Asthma Immunol; 2017 Dec; 119(6):558-559. PubMed ID: 29017903
[No Abstract] [Full Text] [Related]
3. Hereditary Angioedema with Normal C1 Inhibitor: Update on Evaluation and Treatment.
Magerl M; Germenis AE; Maas C; Maurer M
Immunol Allergy Clin North Am; 2017 Aug; 37(3):571-584. PubMed ID: 28687110
[TBL] [Abstract][Full Text] [Related]
4. Hereditary angioedema with normal C1 inhibitor.
Bork K
Immunol Allergy Clin North Am; 2013 Nov; 33(4):457-70. PubMed ID: 24176211
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of lanadelumab in patients with hereditary angioedema with normal C1 inhibitor and FXII mutation.
Bouillet L; Bocquet A; Belbezier A; Boccon-Gibod I
Ann Allergy Asthma Immunol; 2021 Sep; 127(3):391-392. PubMed ID: 34082125
[No Abstract] [Full Text] [Related]
6. Subcutaneous C1 Inhibitor for Long-term Prophylaxis of Hereditary Angioedema: A Real-life Experience.
Baynova K; Cimbollek S; Quiralte J; García R; Lucena JM; Lasa Luaces E; Lara Jiménez MA; Alvarez Nieto J; Moreto J; González-Quevedo T
J Investig Allergol Clin Immunol; 2024 Jun; 34(3):198-199. PubMed ID: 37796634
[No Abstract] [Full Text] [Related]
7. Prophylaxis with anti-activated factor XII for hereditary angioedema.
Fijen LM; Levi M
Lancet; 2022 Mar; 399(10328):889-890. PubMed ID: 35219374
[No Abstract] [Full Text] [Related]
8. Hereditary angioedema with normal C1 inhibitor and factor XII mutation: a series of 57 patients from the French National Center of Reference for Angioedema.
Deroux A; Boccon-Gibod I; Fain O; Pralong P; Ollivier Y; Pagnier A; Djenouhat K; Du-Thanh A; Gompel A; Faisant C; Launay D; Bouillet L
Clin Exp Immunol; 2016 Sep; 185(3):332-7. PubMed ID: 27271546
[TBL] [Abstract][Full Text] [Related]
9. Successful C1 esterase inhibitor therapy in a child with a novel type 3 hereditary angioedema-like syndrome.
Rasmussen JL; Park MA; Fischer PR
Ann Allergy Asthma Immunol; 2012 Jun; 108(6):462-3. PubMed ID: 22626603
[No Abstract] [Full Text] [Related]
10. Use of Concentrated Plasma-Derived Subcutaneous C1 Inhibitor as Long-Term Prophylaxis in an 8-Year- Old Child With Hereditary Angioedema.
Lasa EM; Herrero L; Martínez S; Arruti N; Oliver P; Joral A
J Investig Allergol Clin Immunol; 2023 Jul; 33(4):302-304. PubMed ID: 36000819
[No Abstract] [Full Text] [Related]
11. Treatment of Hereditary Angioedema.
Caballero T
J Investig Allergol Clin Immunol; 2021 Feb; 31(1):1-16. PubMed ID: 33602658
[TBL] [Abstract][Full Text] [Related]
12. Use of pdC1-INH concentrate for long-term prophylaxis during pregnancy in hereditary angioedema with normal C1-INH.
Garcia JFB; Takejima P; Veronez CL; Aun MV; Motta AA; Kalil J; Pesquero JB; Giavina-Bianchi P
J Allergy Clin Immunol Pract; 2018; 6(4):1406-1408. PubMed ID: 29439936
[No Abstract] [Full Text] [Related]
13. Hereditary angioedema with normal c1 inhibition.
Bork K
Curr Allergy Asthma Rep; 2009 Jul; 9(4):280-5. PubMed ID: 19656474
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human C1 esterase inhibitor as short-term prophylaxis in patients with hereditary angioedema.
Valerieva A; Staevska M; Jesenak M; Hrubiskova K; Sobotkova M; Zachova R; Hakl R; Andrejevic S; Suiter T; Grivcheva-Panovska V; Karadza-Lapic L; Soteres D; Shapiro R; Rumbyrt J; Tachdjian R; Mehta V; Hsu FI; Zanichelli A
J Allergy Clin Immunol Pract; 2020 Feb; 8(2):799-802. PubMed ID: 31437566
[No Abstract] [Full Text] [Related]
15. Clinical features of genetically characterized types of hereditary angioedema with normal C1 inhibitor: a systematic review of qualitative evidence.
Bork K; Machnig T; Wulff K; Witzke G; Prusty S; Hardt J
Orphanet J Rare Dis; 2020 Oct; 15(1):289. PubMed ID: 33059692
[TBL] [Abstract][Full Text] [Related]
16. Hereditary angioedema with normal C1 inhibitor: clinical characteristics and treatment response with plasma-derived human C1 inhibitor concentrate (Berinert
Bouillet L; Boccon-Gibod I; Gompel A; Floccard B; Martin L; Blanchard-Delaunay C; Launay D; Fain O
Eur J Dermatol; 2017 Apr; 27(2):155-159. PubMed ID: 28251901
[TBL] [Abstract][Full Text] [Related]
17. Long-term prophylaxis with C1-inhibitor concentrate in patients with hereditary angioedema.
Pedrosa M; Lobera T; Panizo C; Jurado J; Caballero T
J Investig Allergol Clin Immunol; 2014; 24(4):271-3. PubMed ID: 25219111
[No Abstract] [Full Text] [Related]
18. Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema.
Zuraw BL; Busse PJ; White M; Jacobs J; Lumry W; Baker J; Craig T; Grant JA; Hurewitz D; Bielory L; Cartwright WE; Koleilat M; Ryan W; Schaefer O; Manning M; Patel P; Bernstein JA; Friedman RA; Wilkinson R; Tanner D; Kohler G; Gunther G; Levy R; McClellan J; Redhead J; Guss D; Heyman E; Blumenstein BA; Kalfus I; Frank MM
N Engl J Med; 2010 Aug; 363(6):513-22. PubMed ID: 20818886
[TBL] [Abstract][Full Text] [Related]
19. Initial use of subcutaneous plasma-derived C1 inhibitor in prophylaxis of acute attacks of hereditary angioedema in pregnant patients in Slovakia.
Hrubišková K; Jeseňák M; Payer J
Vnitr Lek; 2023; 69(4):265-268. PubMed ID: 37468297
[TBL] [Abstract][Full Text] [Related]
20. Long-term Prophylaxis with Androgens in the management of Hereditary Angioedema (HAE) in emerging countries.
Guo Y; Zhang H; Lai H; Wang H; Chong-Neto HJ; Valle SOR; Zhu R
Orphanet J Rare Dis; 2022 Nov; 17(1):399. PubMed ID: 36324138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
